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ntroducton:
The polyunsaturated fatty acid,

(AA},

arachidonic acid

can be converted through cyclo-oxygenase

and/or lipoxygenase

catalyzed reactions to form prostaglandins, thromboxanes,
leukotrienes

(62),

However, RA must

and other products

(for

review see

76).

be available to these enzyme systems as a

free fatty a.ci in order for these metabolic reactions to

take place

(48,101). Free AA levels

very low concentrations within cells
comprise

a

are normally held to

(39,47)

substantial proportion of the

acid in cellul.r iipi8 pools. Generally,
with

complex

lipids

and yet AA may

coustituent

AA is est.erified
esters

cholestery!

including

fatty

tzigiycerides, and phosphoiipds. Release of AA from complex
].ipids is

her.,eore a physiological prerequisite

production of
of

eicosanoid

prostanoids

in

cell

metabolites.

While

and

physiology

tissue

recognized for several decades,

the

for th

importance
has

been

it is only recently that

considerable progress has been made in the understanding of
mechanisms

regulating AA release

from

cellular

iipids,

primarily phospholipids.
Unique to the process of AA metabolism is the capacity
for cells to selectively release AA from phospholipid stores

following membrane perturbation with a variety of agents
including hormonal, chemical, and mechanical stimuli. In

addition, increased AA metabolism is frequently accompanied
by rapid compositional changes in membrane phospholipids,

alterations in membrane fluidity,
associated Ca ++ levels,

increased levels

and alterations

(68). The interdependence

of cell

enzyme activity

in

of these events in regulating AA

as yet, not clearly defined. In addition,

metabolism is,

the ubiquity of increased AA metabolism following membrane
perturbation

is

by no

means

throughout the

established

spectrum of cell types existing in nature
The purpose of this investigation was to examine AA

metabolism in two cell types which have not been previously
characterized

exam

ned

!7,2’ "8,

(PT[).

in

in

the

AA

was

metabolism

clonal

osteoblast-like

ce].,l

first

line,

stimulation with .larahyroid ho’mone

*o!lowing

RCS

respect.

this

!7/2"8 cells

have

been

shown

to

release

physiolog.ically significant amounts of the AA metaboliC, e,
prostaglandin E 2

these

cells

several

(PGE 2),

demonstrate

biological

in

culture

membrane

responses

(71)

in

addition,

receptors for PTH and

to

PTH

thought

to

be

characteristic of osteob!asts, i.e., increased cyclic-AMP

(cAMP) levels and decreased

alkaline phosphatase activity

(54) AA metabolism was also

examined in human mononuclear

phagocytes (HMP) following stimulation with the complement
fragment, C3b, or lipopolysacchide (LPS). C3b and LPS have
been shown to stimulate immunoreactive

(PGE) and thromboxane B 2
isolated HMP in culture

stimulated monocytes

(TXB2)

prostagiandin E

release

from

(72,80). Prostaglandin

and/or macrophages

freshly

release from

may be important in

the pathogenesis of chronic inflammatory diseases including

periodontal disease.

Literature Review:
acid

Arachidonic
of

synthesis

serves

as

(PG)

prostaglandins

(LT),

prostacyclins leukotrienes

substrate

the

for

the

thromboxanes,

and other products. The

end products of AA. metabolism are not stored in cells or

tissues

but

are

rapidly synthesized and released following

cell

appropriate

stimulation

notable exceptions,

(42,91).

With

only

few

a

the biological effects of eicosanoid

metabolites are thought to

occur locally in the

area

of

release as the.se compounds are generally very labile. The
importance of PGs and LTs in cell physiology is .evidnced.by
the

multitude

various

of cell and tissue

o2cosanoid products.

regulatory roles

important

digestive function

(50),

reproduction

(69),

in

effects

manifested by

th

PGs have been shown to play
inflammatory

reactions

(99)

cardiovascular and renal physiolgy

(27),

platelet aggregation (5 ).

systemic

homeostasis

(41),

and

Thromboxane and prostacyclin are

also very important in systemic homeostasis and platelet
function
been

(2). The recently

discovered leukotrienes

have

not

extensively characterized with respect to cell and

tissue effects with one notable exception.

substance

of

anaphy!_axis

(SR o A),

Slow reacting

identifiable

for

several

decades only as an activity, has recently been shown to be a
mixture of leukotrienes C 4 and D
production

4 (3).

While AA metabolite

has been recognized as an important mechanism

for modulating cell and tissue function,

there are many cell

Figue

.

Reaction

scheme

for

arachidonic acid to PGG 2 and PGH 2.

for

the

convezs+/-on

of

The prominent feature of

this reaction is the formation of the cyclopentane ring with

closure of carbons 8 and 12.

Arachidonic
Acid

{k"r"
H- AVAVA

O

""

CycoOxygenate

Peroxlda,e

OH

PGH=

PGG_

Figure 2. Selec-te mtabolic products of

PGG2

In additiom

to the depicted metabolites, there are several other
metabolites known to be produced from PGG 2.

PGF:z
OH

"o

H -&
OH

OOH

OOH
OH

OH

O

OH

PGE2

PGG

,

TXA:z

0

OOH

H

H

o

OH

4OH

,.OOH
OH

HHT

vzo. v

v

TXB2

0

Figure 3 Conversion of arachidonic acid to leukotriene B 4

(LTB 4) or

leukotriene

C (LTC/,).

Further alterations in the

glutathione residue of LTC 4 lead to the sequential formation
of

LTD/,,

LTE 4, and

LTF/,.

!!

Arachidonic
Acid

5-HPETE

1
.
0

COOH

LTA4

/
OH

OH

LTB 4

OH

OOH

LTC 4

NHCOCH CH C:FKCL.,OH
2

2

NH

2
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AA for

is ultimately dspendent on the availability of free

enzymatic conversion.

It has also beena general assumption

in the prostaglandin field that the rate limiting step in

the production of eicosanoids is the rate of release of AA
from

lipid

stores

cells

within

(97).

The

release

of

esterified AA from lipid sources is regulated by several
metabolic

However,

pathways

interest has

recently focused

on phospholipid metabolic pathways which lead to release of

AA following stimulation of target cells with hormonal or
chemica!

assoc

agents.

ated

comparable ,’lase

Pr e e r e n t i al

r61ease

preferential

ith

of other

metabolism

phospholipid

Increased

constituent

AA

of

is

without

(369

fatty acids

esse of AA can be attributed in part to the

positio:i

,’pecificity

phospholipids.

of

AA

into,

incorporation

AA is esterified predominantly on the number
saturated

glycerol carbon of phospholipids. Generally,
fatty acids are localized to the number 1

carbon
the

of the

number

2

glycerol

moiety

position

is

moieties

(96), In addition, many cell types demonstrate

of

phospho!ipids

usually

occupied

enrichment for AA in particular

frequently

in

by

whereas

unsaturated

phospholipid

classes,

most

(PC)

and

pho sphatidyl choline

phosphatidylinositol

(PI)

(I).

Although

fatty acid

the

mechanisms

regulating enrichment for AA in certain phospholipids are

poorly

characterized,

those

phospholipids

which

are

principal stores for AA are frequently involved in metabolic

processes which lead to selective release of AA. Several
pathways have been described to date:
Sequential methylation of phosphatidylethanolamine

(PE)

to form PC followed by release of AA from PC through the
action of a PC-specific phospholipase A 2.

2) PI breakdown to diglyceride (DG)

with subsequent release

of AA from DG through the action of diglyceride lipase.

3) Breakdown of PI to DG followed by conversion of DG to
phosphatidic acid (PA). AA is then released from PA through
the action of a PA specific phospholipase A 2.

Fhospholi..d m6thylation and AA release

Two .:incipa! pathways eist -’.n cells for thee synthe, sis
of PC:

1) transfer of phosphocholine from CDP-cholin. to 1,2
catalyzed by CTP:

phosphocho

transferase (81) and 2) three sequential methy!ati.cms of the
amine residue of PE through the action of methyltransferase

enzymes

(12,26).

accelerate

The later pathway has

following

receptor-ligand

been

shown to

interaction

in

a

variety of cell types (31). The methylation process has also
been

associated

with

flipping

of

the

monomethyl-PE

intermediate across lipid bilayers as there is an asymmetric
distribution of methyltransferase enzymes (31).
of events is as follows:

plasma membrane,

on the

The sequence

cytoplasmic side of the

PE undergoes a single methylation through

the action of methyltransferase I and

is

flipped to the

exterior side of the plasma membrane. The monomethyl-PE then

undergoes to additional methylations through the action of

methyltransferase

II

to yield PC.

process is associated with

Stimulation

alterations

of

this

in membrane fluidity

(32), receptor expression (88), Ca dependent processes (40),
and biological responses such as histamine release from mast

cells,

T lymphocyte blastogenesis,

differentiation

(31). This process

chemotaxis,

and cell

is also associated with

increased cellular lysophosphatidylcholine

(lysoPC) levels

and. enhanced release, of AA both resulting from increased

phospholi.ase

A2

(31). In addition, treatmeut

action on PC

of ce.lls .:[th .he methyltransferase inhibitor,

blocks me.t.hylation of

PE, 2) inhibits biological,
3)preve’,,ts the

such a,, ",i-tamine release, and

p encorporated

releas, of

there

is

a

close

effects

radiolabelled

association

between

AA (.i)

Lth

’-,

AA release and

increased phospholipid methylation in certain cell. types,

there is no direct evidence which establishes PC as

the

single source 0f released AA.

FI.-PA cycle and release of AA.

In 1953,

Hokin

and Hokin noted, that acetylcholine

stimulated rapid uptake

pancreas

(33).

This

of

finding

32p04
led

into

PI in exocrine

to the proposal that

phospholipid metabolism might be intimately related to the
action of this neurotransmitter in pancreatic cells.

The

effect observed by the Hokins described a small aspect of
what is now called the PI-PA cycle.

According to current

evidence, hormonal
is

or

chemical stimulation of certain cells

associated with rapid degradation of PI thro.ugh the

action of a PI specific phospholipase C

breakdown

This

DG

may

then

undergo

enzymatic

(DG)

I ,2-diacylglycerol

yields

phosphoinositide.

(7).

and

phosphorylation

through the action of diglyceride kinase to produce PA or

may be cleaved to monoglyceride and AA through the action of

PA can then be reconverted to PI

(6).

diglyceride lipase

through the action of two enzymes,

I ,2-diacylglycerol-inositol

CDP

and

transferase

CDP-phosphatidate cytidyl

The

phosphatidyltrnsferase.

salient

of

features

this

pathway are depicted in Figure /.
Stimulated

phospholipid labelling

cycle hs been described for platelets

(25), macrophages (.4),

(22),
of

and others

hormones

or

(33,67),

renal tissues

?githu.n

th PI-PA

(7) rcu.trophils

(!5), neural

tissues

following treatment with a variety

cAemicals.

As

was

described

earlier,

stimulation of phospholipid turnover in the PI-PA cycle can
be associated with increased release of AA either from DG

through DG lipase

(6) or from PA through

phospholipase A 2 (8).

a

PA specific

In addition to increasing AA release,

.

DG has been shown to stimulate

protein kinase C activity

(42,92). Also, lysophosphatidic

the PA-PI cycle may contribute
several other mechanisms

acid

has

been proposed to

to cell stimulation through

act as a

ca

ionophore in cell

membranes (49) and has been shown to promote Ca permeability

16
Figure /.o Phosphollpid turnover in the phOsphatidylinositolphosphatidate

cycls.

Phosphatidylinositl is rapidly broken

down to diglyceride (DG) and

PI

specific

inositide

phospholipase

C

(a).

through the action of

DG

is

then

either

d.eacylated through DG lipase (c) to yield monoglyceride and
arachidonic acid (AA) or is phosphorylated through DG kinase

(B) to produce phosphatidic

acid

(PA). Phosphatidic

acid may

then be deacylated through the actionof phospholipase A
2

(d) to yield AA and lysophosphat+/--d+/-c

acid

(LPA) or can be

converted to PI through the action of CDP-phosphatidate

cytidyl

tansferase

(e) and CDP 1,2-diacylglycerol-i.nos.?cl

phosphatidyltr.nsferase.

PI
CDP-DG

PA
d

AA

LP

AA

18
in artificlal lipid bilayers

(84). In summary, increased

phospholipid turnover in the PA-PI cycle has been associated
with

and/or

may elicit a variety of molecular signals in

stimulated cells including increased release of AA.

Recently,

group

another

of

polyphosphoinositols,

the

phospholipids,

breakdown

_rapid

has

of

observed

been

following hormonal or chemical stimulation of several cell

types

(4,30,60).

Although

the

breakdown

these

of

phospholipids has not been directly linked to a stimulation
of

the

AA release, they appear to be of sufficient importance to
previouslv

mentioned

described

here.

phospholipid proceses to b.

Polyphosphoinositols

phosphatidylinositol

,5--bisphosphate

phosphatidylinositol .-diphosphoinositol

include

(PIP 2)

and

(PIP ) whifzh

constitute quantitatively minor phospholipids in biological

membranes.

Following

stimulation

hormones or neurotransmitters,

of

certain cells

with

PIP and PIP 2 are rapidly

hydrolyzed by phospholipase C to form inositol bisphosphate
and inositol trisphophate,

respectively,

as well as DG (4)-

This process is similar although more rapid in onset than
the previously described breakdown of PI in the PI-PA cycle

(4).

Inositol triphosphate then stimulates the release of Ca

from internal cellular stores

(56) whereas DG stimulates

protein kinase C activity as described previously

(42,92).

Ca release from internal stores is thought to precede the
influx of Ca from

extracellular medium which in many cases

is

associated

in

with the previously described alterations

phospholipid metabolism and increased release of AA.

However, there

is no evidence to date suggesting a cause and

effect relationship between PIP and PIP 2 breakdown and Ca
influx

On

cells.

into

the

between

inte rr elat i onshi ps

the

hand,

other

PI-PA

cycle

the
and

polyphosphoinositol breakdown togethen.with the relationship
between inositol trisphosphate production and Ca release
from

Intracellular stores suggest that these processes

are

at least indirectly related to stimulation of AA release.
Variatiom in me,chanisms of AA release between cell types.,,
The

,.eviously described phospholipid

metabolic

athway e not found in all cell types nor are
oriy path,,ays known to exist.

The mechanisms

they

the

of AA release

from phospholipids can vary between tissues, between

types within the same tissue,, and within the same cell type
depending on the

release

from

and

species

human

stimulus.

neutrophils

For example,

treated

with

AA

synthetic

chemoattractant occurs primarily through phospholipase A 2

cleavage of PI (103). Following stimulation of human
platelets

through

with

the

thrombin,

action

of

AA is

released

phospholipase

on

predominantly

PC

peritoneal macrophages stimulated with zymosan,

(104).

In

deacylation

of PI appears to be the dominant mechanism for the release
of AA

(20). In contrast, Kroner, et al have shown that free

AA levels are primarily regulated by reacylation mechanisms

2O

reactions

catalyzed

lysophosphatide-acyltransferase

involving

(45) Finally, there are many cell types

manifest no alterations in phospholipid metabolism

which

and/or AA

release when treated with appropriate physiological stimuli

(60). In summary,

there are many exceptions to the metabolic

pathways outlined previously for regulating AA release.

Furthermore.
have

not

there are a great number_ of cell types which

been

studied

with

respect

to

phospholipid

metabolism and AA release

The

purpose of this

investigation

metabolism and release from

cell

types.

The

first

was

to study AA

two previously uncharacterized

chapter

describes

ex,periments

examining phospholipid-AA metabolism in the osteoblast-like

c!onal cil R

17/2 8, following stimulation

w+/-th PTH. Th

second chapter describes the partial characterization of AA

metabolism in human peripheral blood m0nocytes i_n v_i_tr_o_
stimulated

with

lipopolysaccharide.

the

complement

fragment,

C3b,

and

Chapter I.

Arachidonic Acid-Phospholipid Metabolism in ROS

Grown in Microcarrier Culture

21

17/2"8

Cells

22
Abstract:
The present study examined the effect of PTH on arachidonic
acid

and

metabolism

release

from

3HSAA.

prelabelled for 2 hr with

ROS

I 7/2"8

cells

ROS $7/2"8 cells were

first grown in microcarrier culture to obtain large numbers

of substrate attached cells. It was found that PTH

slightly stimulated

3H

K3HSAA

release from

(I0-8M)

prelabelled cells

after 2 hr of hormonal stimulation but not after 3 or
hrs.

In contrast, A23187 (SUM),

potent stimulator of

no+

K3HS

a

Ca +.+

alter [H} ].abel content of R0S

was

ionophore,

release for up to

24

2 hr. PTH

a

did

17/2"8 PE, PI,, orPC

after 2. hr of exposure Additional experiments examined the
effect of PTH on phospholipid

assess

al.(:rations

[32pIP04

PI,

PC,

and

PA

turnover PTH was sCn

in phospho!ipid

to have no significant effect on
in

labelling in order to

[32pIP04

uptake into

17/2"8 cells suggesting

ROS

that

phospholipid turnover is not stimulated following hormonal

treatment.

These results indicate that arachidonic acid and

phospholipid

metabolism

sufficiently affected

by

by

arachidonic acid release as a

production.

ROS

17/2"8 cells

is

not

PTH to implicate endogenous
mechanism for increased PGE
2

Introduction:

PGE 2 release from rodent osteosarcoma clonal cells has
been

correlated

phenotypic

the

with

of

expression

characteristics,

i.e.,

osteoblastlc

decreased alkaline

phosphatase activity and increased cAMP levels following
parathyroid

hormone

cyclooxygenase
including

PGE2,

arachidonic acid

(PTH)

catalyzed

(70).

stimulation

of

production

The

prostanoids,

is controlled by the availability of free

(AA) which

is normally held to very low

"levels within cells (100). Two principal

mechanisms have

been identified whereby cells increase free AA iev!s:,"b9

decreasing the rate of AA acylation into lipid stc:res, within
cells (5). and by increasing the rate of AA release from
lipid st.o.,es

(9). Recently, phospholipid turnover

observed in association with the release of AA from,,varivus
cell types

(29,34,93).

Phospholipid turnover events can be

initiated by receptor-ligand interaction
associated

with

increases

activation of phospholipase C

increased

AA release.

There

in

cellular

(22) and can be
Ca

levels

(56),

and/or A 2 activity (104),
is

no

indicating that receptor-ligand

substantial
interaction

and

evidence

leads

inhibition of AA incorporation into cellular lipids.

to
The

release of elevated amounts of PGE 2 by osteoblastic cells in
culture

indicates

that

arachidonic

acid

(AA)

is

available

for conversion to PGE 2. It has also been demonstrated that

exogenous AA can be converted to PGE 2 by osteob!ast enriched

Recent

shown PTH

also

have

studies

(60,70).

clonal cells

calvaria cells and osteoblast-like

of

stimulation

PGE

(53).

release from osteoblast-enriched cells in culture

The purpose of the this study was to determine whether

PTH can stimulate release of arachidonic acid from ROS

17/2"8 osteoblast-llke clonal cells
regulated

cell

with

release

in a manner consistent

resulting

increased

from

turnover.

phospholipid

Msterials and Methods:
Microcarrier cll culture.

ROS

I. 7/28

cultu:’e

micro,:a’rer

were

cells

passaged

’’..
,.,ro,,n

and

This clture technique as

(MC).

n

Cho::on

because llz"ge numbers of cells are conveniently produccd

reieasin<

e,:vpriment, can be performed without enzymatically

cells

and the entire cell culture can be uniformly

prior

to aliquoting cell

Briefly,

this

samples

technique involves
beads

coated dextran

for

experimental use.

growing cells on collagen

(Cytodex IIi beads, Pharmacia)

maintained in suspension with stirring at
microcarrier spinner flask

beads are 100-150

m

30-35

17/2"8 cells

rpm in a

(250 ml, Bellco). M+/-crocarrier

in diameter and provide

0.2-0.3 m 2/g o

surface area for substrate attached cell growth.
of ROS

labelled

Subculture

was accomplished by aliquoting 30 ml of

confluent bead suspension into a sterile bottle. After the

beads
free

settled,
Hank’s

the

buffer

medium was decanted and

containing 0.01

50 ml of Ca-Mg-

trypsin

(Sigma) was

added to the settled beads.

37C,

min at

After standing for 5

the medium was decanted and a second 50 ml aliquot of

trypsin containing buffer was added The mixture was alloed

to stand for 15 to 20 minutes after which most cells were
released with gentle awirling. The beads were allowed to

settle, the cell suspension decanted and the ROS cells
pelleted and resuspended in F2 medium. Inoculation of a

07

new culture was carried out by adding 2.0 x

cells to a

spinner flask holding 0.5 g of thrice washed Cytodex III

beads

in

50 ml of F-S2 medium containing I kanamycin

s]ifate and

,was

5Z fetal calf serum (FCS). The

then,2tir.red continuous]y for

37C

be,d suspens,ioz

7 days at .5-40rpm at

At two day intervas, cell feeding was accomplished b.

allowing ;he beads to settle followed by medium exchang..e,

5 CO 2 in air
All spinner flasks were wrapped in foil to prevent exposure
Medium was equilibrated with an atmosph.re of

of the proliferating cells to light.

Labelling and hormonal treatment of ROS 17/2"8 cells.
Isotopic labelling of ROS cells
microcarrier
the

5

ml

was

accomplished in a

spinner flask modified with an access hole in

polyethylene
pipette

screw

into

the

top. This permitted insertion of a
stirring

bead

suspension

for

withdrawal of experimental aliquots. Cells were labelled
with either

5,6,8,9,!1,12,14,15-[3H]arachidonic

New England Nuclear) and/or

[32p]orthophosphoric

according to the conditions

described

in

acid

acid

the

(AA
(NEN)

results

Labelled csll samples were placed into glass tubes

section.

37C

and incubated for at least 30 min at

stimulation. For experiments examining

3H]AA

prelabelled cells, 00

l

prior to hormonal

[3HI

release from

samples were taken from

ROS-conditioned medium at designated time intervals and

counted by scintillation spectrometry.

Human -34 PTH (generous gift of Dr. H. Keutman) was
stored at

-80C

(pH 4.0)

with

as a

I0-5M

stock solution in 0.Z Na acetate

For

mg/ml BSA (Fraction V, Sigma).
stock solution as

experimental use, this

dissolved

in

sufficient F-12 medium to deliver the required

total

volume

of

20

l.

All

control

vehicle and shm manipulations.

tubes

received

PI’H

An23187 was store8 at--2.0C

as a 20 mM s’.,-k solution in absolute

Methods for lipid extraction and thin layer chromatography..

For

experiments

examining

PTH effects

on

lipid

labelling, incubations were stopped with the addition of
organic

solvent

to the glass culture tubes holding R0S

cells. Lipids were extracted utilizing
the method of Garbus et al.

a modification of

(24). According to

this method,

each tube containing ! ml of medium plus beads received
of

chloroform:methanol (I. :2)

sonication.

followed by a 10

After standing for 2 hr,

4 ml

second

each tube then received

1.5 ml of chloroform and 1.5 ml of 2M KCI with 0.5M

K2PO 4

(pH 7.4). After vortexing, tubes were centrifuged for 10
minutes at

1000 x g and the aqueous phase discarded. The

.

lower organic phase was then transferred and dried under a

stream of N 2 gas. The remaining cell pellet was then assayed
for DNA using a modification of the method of Burton (13).
Prior

to TLC

standard of 5

separation

g

of

phospholipids,

of phosphatidic acid

an

internal

(PA) was added to each

lipid sample to facilitate identification of labelled PA on

TLC plates.

systems

,sere

solvnt

system B,

solvent

used:

chiorofor.:ethanol triethanola mine
d

LHP-K

(I0 x 20 cm, Whatman). The following

silica gel G plates

solvent

m

TLC was carried out on 0.2

Unidimensional

:H20

chloroform:

system

(’30:34:35
pyridine:fo.ric acid

(50:30.7 v/v) (21). Solvent system A was used to ,separate
phosphatylethanolamne
phosphatidylinositol

(PI),

phospha.t dy serin’s

,..).

and phosphatidylcho!ine

(PC)";

(PE),

whereas solvent system B was used to separate PA and PE from
other phospholipids.
in 20

l

Individual lipid samples were taken up

of chloroform, dried to 5 ul, and spotted on TLC

plates. This was followed by 4 washes of 5 ul each, spotting
each

Following the

wash below the previous one.

separation

of phospholipids, plates were dried and sprayed with I mM 2-

p-toluidinylnap.hthylene
and

lipids

phospholipids

6-sulfonate in 50 mM Tris

visualized
were

with

identified

UV
by

light.

(pH 7.4)

Individual

cochromatography with

authentic standards. Lipid spots were-scrapped and counts

determined using scintillation spectroscopy.

Two dimensional

chromatography according te the method of Yazlhara (107) was
used to verify one dimensional TLC results.

PTH stimulation of cyclic-AMP in ROS cells.
PTH stimulation of R0S 7/2"8 cAMP was assayed for
samples taken from microcarrier culture at days

2,4,6,

and 8

after inoculation. After sampling, the microcarrier beads
were allowed to settle, the culture medium was aspirated,

and the

cells labelled for 2 hr in S

2 FCS,

containing

[HSadenine (New

kanamycin

ml of F-S2 medium

sulfate,

England Nuclear).

The

S

and

medium

Gi/ml

was

then

and the microcarrier pllet washed 3 times with
nedium Ce.,il samples were incubated for
medium containing 2% FCS and

Samples

,.ere

indicated

I hr in I m! of F-!2

I mM isobutylmehy!xanthineo

then treated with hormone or diluent at t’e

concentrations

and

incubated

for

5

Reactions were stopped with the addition of 25

minu,es.

I

of 25%

TCA. Labelled cAMP was then determined according to the
method of Solomon.

(85).

PTH inhibition of alkaline phosphatase activity in ROS
cells.
Alkaline phosphatase activity as assayed in duplicate
control

and

PTH-treated

samples

taken

from

each

microcarrier flasks at the indicated time points.

of

3

After

sampling, the cell medium was supplemented to contain 10 -9 M

PTH or diluent and the R0S 17/2"8 cultures incubated for 48
hr.

Alkaline phosphatase was

soiubilized

with

the

addition

29
of 1 ml of 8o2 Triton X 100 and vortexing. A 50

l

sampla

taken for assay of p-nitrophenylphosphatase activity
according to the method of Lory

(52) as

modified by Majeska

et al. (54). The percent of hormonal-inhibition of alkaline
phosphatase activity (corrected for DNA) was calculated for
each microcarrier flask and summed for all flasks.

Determination of DNA content in ROS cell samplehs,.

DNA was determined by colorometric assay according to a
modificationof the method of Burton

(13). Cell pellets were

taken up in 2 ml of 0.SN perchloric acid and incubated for
,!5

rain

,it,

70C,

vortexing frequently.

Undissolved mater;ial

was then <;entrifuged and the supernatant rem,oved followed

the addition of ! ml of 0.5N perchloric acid. After a second

"15 rain h;drolysis at 70C, the undissolved
pelleted and the supernatants pooled. Fresh diphenylamine

reagent (4 ml) was then added to each of the pooled
supernatants and the Samples incubated for 18 hr at

37C.

Samples were then read at 600 nm against a standard curve of
known DNA content.

All results are expressed as the mean + standard error.
Differences between means were evaluated by the Student’s t

test

as described in the results section.

Results:
Hormonal responsiveness of ROS cells grown in microcarrier
culture

MC has been utilized for the growth and maintenance of

a wide variety of substrate attached cells

(35).

bone cells

(!6), including

The effect of this culture method on cell

properties, such as hormonal responsl.veness, has not been
established.

It was therefore important to compare PTH

responsiveness of R0S

17/2"8 cells grown

in microcarrier

culture with previousl characterized responses for cells

grown on conventional plasticware. Figure I shows the PTH

7/2"8 cAMP levels with

dose dependent stimulation of R0S

increasing time of growth in MC. There does not appear to be

any significant alteration in cAMP response with increasing
bime

MC.

in

Figure 2

shows

PTH inhibition

that

alkaline phosphatase was highly dependent on the time

As

culture.

phosphatse

shown,

maximal

occurs

for

of

inhibition

cells

grown

microcarrier culture. Majeska et al.

for

ROS

alkaline

4-8 d. ays in

(S&), observed slightly

greater inhibition of alkaliue phosphatase with

10-9M

PTH,

assayed on cells grown for 7 days in conventional culture.

[3H]AA

labelling of ROS phospholipids

in mlcocarrler

culture
Phospholipid

extractions

were

carried

modification of the method of Garbus et

out using a

a1.(24). Using this

method, a single chloroform:methanol wash extracted greater
than 92 + 1.6 (3 trials) of the available
R0S

cell

samples

Presumably,

samples,

labelled

as

[3HI

previously

counts in
described.

all label would not be extracted from these

particularly

since

AA does not

efficiently

Figure I. stimulation of R0S

17/2"8 cyclic AMP levels by

PTH. Stimulation of cyclic AMP levels was determined for R0S

7/2"8 cells grown

for

(n=4 for each point).

2(), 4(v), 6(e),

and

8(A) days

in MC

2O

( Day 2
Day 4

15

() Day 6

cp(n

H -cAMP

u, DNA

10

Control

12

11

10

Log (PTH)

9

8

partition into organic solvent in the presence of neutral
pH-high salt aqueous

solvent.

Acidic

facilitate

conditions

the extraction of AA as well as acidic phosphollpids. An

cell samples

additional chloroform:methanol wash of the

recovered

only an additional 3 of

available

total

the

counts whereas reextraction with chloroform:methanol:HC1

2:1:0.4) recovered the remaining

[3H]AA

the majority of

K3HS

counts (4%)

Since

was incorporated into PI, PE, and PC,

the recovery of these phospholipids was assumed to be high

However, the recovery
ost

of PA was of concern because it is the

phosphollpids and it is present in

acid,ic of the

17/2"8 cells.

levels in R0S

Three extraction m,ethods

were compared in their efficiency for PA and PE extraction.

It

was

that

found

a

w i t,h

wash

single

acidic

chloroform:methanol according to the method of Billah et al.

(7), recovered significantly less
than

the

method

reextraction
with

of the

acidic

Garbus

of

et

[3HI

ai.(24).

In

more

counts

in

PE

did

and

addition,

(Garbus method)

extracted cell samples

chloroform:methanol

significantly

labelled PE and PA

not

PA.

recover

All

lipid

extractions in the present study, therefore, utilized the

method of Garbus et al.

(24).

To examine the stability of
phospholipids

prelabelled with

in

microcarrier

[3H]AA

for

[3H]AA

labelling of ROS

culture,

cells

24 hr and transferred

were

from MC to

stationary culture in glass tubes. The time dependence of

Figure

2.

Effect

activity in ROS

of

I0-9M

17/2"8 cells

PTH on alkaline phosphatase
maintained in MC. Cells were

cultured for the indicated period in MC and aliquoted into

glass tubes. Following stimulation with hormone or diluent,

cellswere cultured for 8 hr in glass tubes and harv.ested.
Alkaline phosphatase was standardized against cell DNA.

20"

%S mul ati on

%inhibition

2

8
6
4
Perlod of Growth tn MSC

(Days)

10

12

label redistribution in ROS phosphOlipids was determined
the

from

point

distribution of

of

sample

K3HSAA

transfer.

Figure

3 shows the

in the major phospholipids of R0S

cells following removal from MC. Incubations were terminated
with the addition of organic solvent.

As shown, there is

little redistribution of label following the removal of R0S

17/2"8

cells from MC. Since there was a small decrease in PE

labelling for up to 0 rain after removing cells from MC, all

subsequent experiments allo cultures to equilibrate for at
].east

0 minutes prior to stimulation with PTH.

PTH effects on
Fig.re
label,

3AA

release from ROS cells

4A demonstrates the extent of st

mulation o

appearance in ROS 17/2"8 cell culture medium

following s-timu!.tion with PTH or A-23187, Cells were gro",’,
for 7 to
and

14 days

:in

MC, preiabelied with

washed with unlabelled medium

[3H]-AA

immediately prior to

aliquoting cell suspension into glass tubes.
was

significantly increased

for 24hr,

[3HI

release

(p<O.05) by 12 hr of PTH

treatment whereas 3 and 24 hr of hormone exposure were
without significant effect. Figure,%B depicts the release of

label from a representative cell preparation. Consistent
with

the

capacity of

phospholipase activity

A-23187 to stimulate Ca dependent

(65),

the release of

[3H]

label from

R0S cells was markedly stimulated with A-23187 treatment.
The magnitude of the Ca ionophore effect indicates
is not a

that PTH

potent stimulus of this process. The PTH stimulated

Figure 3. Effect of removing R0S

17/2"8

label distribution in major phospholipids.

cells from MC on

Cells were grown

for 7 days in MC and labelled only for the last

[3H]AA (1 ,uC+/-/lO0

24 hr with

ml). Al.quots of the cell suspense.on were

transferred to glass tubes at time 0 and organic solvent
added at the indicated time points. Each point represents
the

mean

+

S,.E,

approximately 1.5 x

content.

for

106

6

trials.

cells

/

Samples

contained

tube as determined by DNA

2O

15

cpm x 10

c’

Sarr.le
10

5

10

15

30
Minutes

60

Figure 4. PTH stimulation of

prelabelled R0S

Cells

24

were

3HAA

label release from

17/2"8 cells. Cells were grown

in MC and labelled for
suspension.

3H]

for

7-I days

hr prior to dispensing the cell
washed

with

unlabelled

medium

immediately before cell suspension was transferred to glass
tubes (5 ml aliquots).

[3H]

appearance was quantitated by

removing 0.5 ml of culture

Supernatant at

Results

as

points.

are

depicted

the indicated time

stimulation

of

[3H]

release in (A) and a representative release experiment in
10 -8 M PTH

(B). Results are for
ad /ehic_]..e cortrol

mean

+_

w.

(@). Each point in (a) represents

E. _or 7 points Significant stimulatin was

observed f,r (a)

(!0-5M)

( m ), 5 uM A-23187 (v),

I0-8M

PTH at 12 hr (p<0.05) and (b) A-23187

at 12 and 2 hr (p(O.O05).

A

10-6M A23187
(=1) I0-8M PTH
(’) ,5x

T/C

3

12

24

B
Medium

0.5

cpm
m|

IOO0
3

12

24

release in these experiments was obserzed only when labelled

cells were washed with unlabelled medium prior to hormonal

treatment. When 24 hr prelabelled cells were stimulated

3H

PTH had no effect on medium

without exchanging medium,

content (data not shown).

within

3HI

shows the distribution of

Table

R0.S17/2"8 phosphollpids

cultures at I rain and

in control and

32p

label

PTH treated.

after hormone addition. Cells

24 hr

3HAA

prelabelled for 24 hr with either

wets

and

or

32pP04

prior to stimulation. The medium was not exchanged prior to

aliquoting

samples,

cell

in

effort

an

to

maintair. .he

approp’ia.e steady state for determining PTH effects. PTH a t

0-’SM

or

I0-10M

dis,tribution

had no significant effects on

in

ROS

phospholipids.

[3H]

or

In addition,

24

exposure to PTH had no significant effect on DNA content of
R0S

17/2"8
The

cultures.

increased rate

[3HI

of

release

observed following

PTH treatment of R0S cells might result from a stimulation
of phospholipid metabolism without affecting the long term

labelling of phospholipids. This process can be monitored by
measuring

the

uptake

of

label

following hormonal stimulation.
dependent uptake of

[32p]P04

without PTH treatment.

R0S

labelled for 2 hr with I00
medium.

At

that

time,

into

phospholipid

Figure 5 presents

the

pools
time

into R0S phospholipids with and

cells

maintained in

Ci [32p]P04/200

aliquots

of

ml

MC

were

of F-12

cell suspension were

Tabl e

CPM/Cell Sample

I0-8M

Phospholipid

PTH

I0

-tOM

PTH

Control

3H-PC

5619 _+ 353

5750 _+ 234

5824 _+ 748

32p-PC

7563 + 1696

15560 + 657

16533 + 3112

3H-PI

3892 + 443

3577 + 41

3578 + 354

32p-PI

3577 _+ 4

3565 + 324

3387

H-PE

783S + 712

7593 + 602

7560 + 765

3:P-PE

6569 + 1069

6450 + 984

6673

23.7 + 2.3

25.6

Z

,323

DNA (ug/ce!l sample)

25.6 + 1.9

Table

.,

Effect of PTH on

[3H]AA

17/2"8 phospholipids Cells
labelled for 24 hr with

<50Ci/200ml),
suspension

was

and

32p

[3H]AA ( Ci/100ml)

Without exchanging medium,

transferred

coincidence,

for 5 trials,

content of ROS

were grown for 6 days in MC and

to

treated with hormone or diluent,
for

[32p]PO 4

.glass

3H

and

[32p]-PO 4

labelled cell

culture

tubes

and

counts were corrected

All data are expressed as mean + S.Do

Figure 5.

The effect of PTH on

17/28 phospholipids. Cells
labelled for 2 hr with

transferring

cell

uptake into R0S

were grown for 7 days in MC and

[32p]-P04 (100Ci/200ml)

suspension

cells_ube). Hormone (10-8M) (1)
0 min.

[32p]P04

to glass
or diluent

tubes

prior to

(1.5 x

106

(@) was added at

Each point represents the mean + S.E. for 3 trials.

(e) Conoi
(I)

O’-SM PTH

120
cpm

32

P

ug D,;A
8O

-10

0

30
Minutes

Hormone
Treatment

PC

placed in glass tubes and incubations were stopped at th

K32pSPO 4

significantly alter

PTH treatment did no t

As shown,

.ndlcated time points.

uptake into PC,

PE, and P I

during I hr of of hormone treatment.

not been possible

Although it has
induced

in ROS

phospholipids

[3H]AA

in

alterations

cells,

the

to

identify PTH

content of

the

small increase

major

in

release from PTH-treated ROS cells allows the possibility
that label is bsing released from quantitatively minor lipid

classes. Phosphatidic acid (PA) is generally found in

ver

low levels in cells, yet

rapid phosphor$lation of PA’ canbe

o,served,ithin seconds

to minutes following chemical or

horizontal ,timulation of certain cell types. The follo.ing
experime,,ts

whether

examined

PTH

could

promote

PA

phosphorylation in ROS cells. Figure 6 shows that PTH had no

[32p]PO 4

effect on

uptake into PA in ROS 17/2"8 cells nor

[3H]AA

was there any effect on

[32p]PO 4

(2 hr) was utilized to measure PA turnover

label

term

whereas

long

reflect

alterations

labelling
labelling.

content in PA. Short term

was

[3H]AA
in

(24 hr) was

thought

to

PA arachidonic acid content.

PE

included

label

as

a

reference

lipid

for

PA

46
Figure 6. The effect of PTH on

[32p]PO

uptake and

[3H]AA

content of phosphatidic acid in ROS 17/2"8 cells. Cells were
grown in MC for 6 days followed by 22 hr labelling with

[3H]AA (I

Ci/

100ml). The MC medium was then exchanged with

phosphate free Hanks salts and cells labelled for 2 hr with

[32p]PO 4 (10

Ci/

lOOm.l). Suspension aliquots were then

transferred to glass tubes (1.5 x
stimulated with

s o-SM

S06

cells/tube) and cells

PTH (m) or diluent (@). Data points

represent the mean _+ S.E. for 5 trials. PE was included as a
reference

lipid.

(1) Conol
25

(e)

o-SM PTH
H-PE

20-

!5-

t0-

cpm x 10

3

Sarr.,e

H-PA.

2
Minutes

3

Discussion:

Microcarrier culture provides

an

efficient technique

of substrate attached R0S

for growing large numbers

17/2"8

cells. In addition, aliquots of confluent bead suspension
demonstrated a high degree of uniformity with respect to DNA

content and label distribution in phospholipids. In these
it

experiments,

harvesting

cells

of

to avoid mechanical

was also important
in

aqueous

medium

prior to organic

Solvent e.xtraction of phospholipids as this manipulation can

affect

phospholipid

metabolism

.onventional plastic dishes

(! 7).

grown on

Cells

must be mechanically harvesbd

prior to ,extraction of lipide since organic solvent will

dssolve

,ost plastic vessels.

microcar’:er

By aliquoting cells from

culture to glass tubes,

it as possible

hormonally stiulate cells and extract phospholipids in the
same vessel without an intervening mechanical harvesting.
The PTH responsiveess observed for R0S

17/2"8 cells

grown in MC was comparable to that previously observed for
cells

grown on conventional plasticware.

The

cAMP dose

response for R0S 17/2"8 cells grown in MC was virtually
identical to that reported for cells grown on plastic
Maximal

stimulation

of

cAMP levels with

approximately 10 fold (see figure

prevously reported (5+). However,

I),

I0-8M

(54).

PTH -was

somewhat less than

cAMP stimulation was

evaluated several times over the course of the current study
and

maximal

stimulation of

cAMP with

I08M

PTH

was

approximately 60 fold.

subsequently found to be

The

therefore, appears to be

magnitude of the cAMP response,

dependent on additional factors beyond hormone dose alone.

PTH

(S0-9M)

inhibition of alkaline phosphatase in ROS

cells grown for 7 days in MC was also reduced when compared

reported responses observed with cells grown

to previously

for 7 days on plastic

(5). However, these cultures were

assayed ,for PTH inhibition of alkaline phosphatase at the

same time that reduced cAMP responses were observed. No
additional asaays were attempted to determine whether PTH
.mhibitlon. of alkaline phosphatase varied as widely as cAMP

To our know].edg

responses to a given dose of horzone.
’these

results are the

to

first

hormonal

demonstrate

r.sponsive.ness of osteoblast-like cells growr iu C.
The appearance of

labelled R0S

capacity

[3HI

in medium conditioned by

17/2"8 cells treated

of

microcarrier

with

grown

[3H]AA

A-23187 reflscted the
cells

to

release

preincorporated arachidonic acid. Relative to the A-23187

[3H] release. PTH
of [3HI only when

effect, PTH had only a slight effect on
was

found,

to

stimulate

the

re!ease

labelled cells received fresh medium immediately prior to
hormonal stimulation. The increased release of

[3HI

in these

experients presumably represents a more rapid rate of tracer

release from PTH treated cells.

However, cells

which did not

receive fresh medium demonstrated no increased release of

[H]

label

into

the

surrounding

medium

after

24 hr PTH

treatment (data not shown). These results suggest that a net
release of

EHS

label from R0S cells is required to observe

PTH effects on label release.

Interestingly,

17/2"8 conditioned medium were

R0S

3HS

levels in

2 hr of

identical after

culture regardless of whether cells were maintained in MC or
in glass tubes

(data not shown).

Stimulated release of

K3HS

following treatment with A 23187 indicates that R0S cells

possess the capacity to release increased amounts of AA with
appropriate stimuli. However,
in

K3HS

increase

the relatively small

release folloing PTH treatment suggests that this

hormone is not. important in this process.

Attempts to identify alterations in

[3H]AA

contert of

phospholipids in R0S i7/2"8 cells following PTH treatment

iolded negatAve results These experiments examined
content of R0S phospholipids

for

up

to

24

of

hr

[]
PTH

exposure. Label incorporation into major phosphoiipids after

[3H]AA was unchanged after an additional
with I0-8M PTH. These results indicate that

2 hr exposure to

24 hr

incubation

PTH does not selectively transfer AA from or between the
major phospholipids in ROS

17/2"8cells. That phospholipid

metabolism was not affected by 24 hr exposure to PTH was
also

R0S

supported by experiments utilizing

17/2"8 cells

were

labelled for

according to the scheme described for
WaS

demonstrated

that

[32pIP0 4

[32pIP04

24 hr

[3H]AA

with

as

tracer.

[32p]p04

labelling. It

content

of

major

phospholipids in R0S cells remained virtually unchanged for

2& hr control and. PTH treated cultures. In summary, PTH
treatment was without effect on

[3H]AA

release from major

phospholipids in ROS cells and was unab-le to alter

[32p]PO/,

labelling of phospholipids.

label into Roe

PTH-stimulated release of

17/2"8

conditioned medium might be a manifestation of altered AA
resulting

metabolism

Enhanced

from

increased

phospholipid

turnover.

AA release has been directly associated with

stimulation of phospholipid turnover in a variety of cell

types following stimulation with
certain

chemical

agents

cell, specific

(34,93).

hormones

Generally,

or

e t aboli c

observed

labelling consistent Tith increased turr.over

within seccnds to minutes following cell stimulation and is
liited to, certain phospholipid metabolic path,as.

major pathways have been identified to date:

Two

I) sequential

methylation of PE to PC with subsequent release of fatty
acid

from

PC

(31)

polyphosphoinositols

and

2) rapid breakdown of PI and

(DPI and TPI) to diglyceride with

subsequent synthesis of PA and/or release of fatty acid from
diglyceride

(04).

In

dog

kidney

slices,

[32p]PO

incorporation into PI, TPI, DPI, and PA is stimulated within

5 minutes of PTH treatment in a manner consistent with
increased phospholipid turnover

(58).

PTH was shown to have no effect on

PC,

and

In the present study,

[32p]PO4

uptake into PI,

PE for up to 60 minutes of hormone exposure.

Additional experiments also demonstrated that PA

labelling

in ROS

17/2"8 cells was unaffected by PTH treatment. These

findings, therefore, indicate that PTH does not stimulate
phospholipld turnover in R0S cells in a manner comparable to
that previously observed in another PTH target tissue, the

kidney.

In conclusion,
indicats

that

metabolism

of

PTH

the

results

do,es

3HS-AA

in

the

of

present study

not

sufficiently

R0S

cells

affect

the

to be considered an

important factor in endogenous AA metabolism in this cell

type. The apparent capacity of R0S 7/2"8 cells to release
,_g
signiflcart quantities of PGE 2 may relat to unusually i
basa. 1 phospholipid turnover

(69) althouho th possibility

exogenous AA is the predominant

that

substrate

in

FGE 2

proluction cannot be excluded. In ay cas,
s, nd

phospholipid metabolism does not appear to be regulated

by PTH such that increased production of PGE 2 #ould result
from release of AA from endogenous esterified AA sources.
This does not exclude the possibility that PTH may affect

phospholipid

metabolism

and

AA release in non-transformed

osteoblasts or in another subgroup of osteoblastic clonal
cells.

Chapter 2.

C3b and LPS stimulated release of PGE and TXB 2 from human
morlonuclear phagocytes in culture: Evidence for independent
conversion of arachidonic acid to PGE
2 and

TXB2o

Abstract:

v3b treatment of human peripheral blood mononuclear
phagocytes

(HMP)

in culture

stimulates an early release of

thromboxane B 2 (TXB 2) and a delayed release of prostaglandin

E

(PGE)

into

culture

supernatants.

We

examined

C3b

3H-arachidonic acid (AA)
time course of 3H release

stimulated eicosanoid production in

prelabelled HMP by comparing the

from HMP.phospholipids with the appearance of

PGE 2,

and AA in culture supernatantso

TXB2,

H-labelled

In addition, we
PGE and

compared the time course of immunoreactive

TXB2

rslease with radio.abelled PGE 2 and TXB 2. Identification and
quantitation of radiolabelled AA

metabolites

was

performed

by TLC and results were corroborated by high pressure !iquAd

clromatography (HPLC). Following C3b treatment of
time course of radio!abei!ed

the

stimulated

phosphoiipids corresponded

the

TXB 2 release was found to be

conparable to TXB 2 measured by radioimmnoassay

addition,

HMP

release

o

of"

3H

label

(RA). In
from

HMP

the appearance of labelled

TXB 2. However, radiolabelled PGE 2 release was maximally
stimulated by 8 hr of C3b treatment whereas immunoreactive

PGE release

was

maximally

stimulated

after

treatment. In addition, stimulated release of

1 6 hr of

[3H]AA

into

culture supernatants was observed prior to any detectable

increas=d release of lab lied TXB 2 or PGE 2.

he

apparent

differential release of immunoreactive PGE vs JH-labelled

PGE 2 from C3b treated HMP was further examined by measuring

HMP eicosanoid release following treatment with bacterial
lipopolysaccharide

(LPS). It was found that LPS

stimulate labelled PGE 2 release
stimulated release

from

did not

HMP but significantly

of immunoprecipitable PGE after 8 hr of

treatment. As with C3b stimulation of HMP, the appearance of

[3H]AA

in HMP culture supernatants did not parallel labelled

TXB 2 or PGE 2 release following stimulation with LPS.
results are
and

PGE 2

consistent with
in

relationship

stimulated
between

production in HMP.

AA

These

independent metabolism of TXB 2

HMP

and

metabolism

suggest
and

a

TXB 2

complex
and

PGE 2
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Introduction:

(MP)

Monocytes and macrophages
release

of

significant quantities

metabolites

following

(72),

ionophore,

A-23187 (I06),

antigen-antibody

released by the MP include
stable breakdown product of
and HETES

(3), LPS (75),

6-keto

PGI1), PGFI,
is

and other

metabolites shown to be

TXB2, PGE2

(82). Although there

(AA)

C3b cleavage
complexes (63), Ca ++

concanavalin A

(38). To date, the principal

to

with

zymosan (02), phorbol myristate acetate (37),
factors

shown

arachidonic acid

stimulation

fragments

been

have

PGFI

leukotrienes

(th_e

(10),

considerable variation in

the production of these eicosanoids from MP preparations

(82,23,6),

the production and release

of AA

metab,olites

i.s

thought to be limited by the availability of free AA to
cyclooxygenase and lipoxygenase

systems

enzyme

(86).

Since

free AA is normally restricted to very low levels within

cells,

the regulation of AA release

stores

appears

to

determine

the

from

rate

of

cellular lipid

AA

metabolite

production. Two mechanisms have been reported which account
for

increased free

These are

AA levels in stimulated macrophages.

1) increased release of AA from phospholipids

primarily through the action of phospholipase A 2 (100) and

2) decreased reacylation of AA into lipid pools (5). AA
constitutes 20% of the esterified fatty acid in rabbit MP

(57) and in human monocytes (87). In addition, labelling
experiments demonstrate that AA is selectively incorporated

into phosphatidylcholine

(PC), phosphatidylinositol (PI),

and phosphatidylethanolamine

(PE)

(83) and that

in rodent MP

rapid turnover of these phospholipids

accompanied by

is

selective AA release following stimulation with certain

(80). Although

fac_tors

stimulated

AA metabolite production

appears to be consistent with enhanced AA release from MP
phospholipid stores,

direct

correlation

of the

time

course

of AA release from MP phospholipids with the appearance of
eicosanoid pro-ducts has not been established.

Increased immunoreactive PGE and TXB 2 release has been

observed ,from human mononuclear phagocytes (HMP)
in culture for

endotoxin

2 hr

in the presence on C3b,

maintain.ed

iC3b, C3c (72),

(LPS) (80), and antigen-antibody complexes (73).

These studies were unique in that highly enriched HMP
first obtained from freshly drawn blood through the

use

of

counterflow centrifugation (CC) (74). This technique permits
rapid

of

enrichment

HMP

suspension,

in

selective adherence in mixed culture

frequently

used

technique

to

isolate

thus

avoiding

which is the

MP.

most

Utilizing

CC

separated HMP, it was shown that 24 hr cultures exposed to

C3b

demonstrated

decreased

PI

levels

and

increased

lysophosphatidylcholine (LPC) and sphingomyelin levels when
compared to control cultures

(42). Although these findings

support the proposed relationship between AA release from
lipid

stores and subsequent conversion to eicosanoid

products,

there is no direct evidence demonstrating release
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of preesterified AA in C3b stimulated HMP and subsequent
conversion of released AA to eicosanoid products.
here

We report

experiments which examine this relationship in C3b

treated HMP by comparing the time

course of labelled AA

release and conversion to metabolites with the release of
immunoreactive eicosanoids. In addition, labelled metabolite
release was examined afte.rtreating HMP with LPS.
Materials and Methods:

Materials.

K3HSArachidonic
[3HSPGE 2

(113 Ci/mmole), and
from

New

England

Nuclear.

acid

(87 Ci/mmole),

(165 Ci/mmole) were purchased
were

Phospholipid standards

obtained from Supelco. Arachidonic acid,

toluidinylnaphthylene 6-sulfonate

(TNS),

PGE 2, 2-p-

TXB2,

penicillin

ant

streptomycin were obtained from Sigma Chemical Co. MCDB 104
was purchased from Flow Laboratories. Anti-PGE 2 antibody

(generous gift

of Dr.

Lole) and anti-TXB 2 antibody (Seragen)

were used for radio+/-mmunoassay.

Fetal calf serum

obtained from Hyclone Laboratories.

(FCS) was

C3b was prepared by by

mild tryptic cleavage of purified C3 and separated from C3a

by gel filtration on Sephadex G-75 or Sephacryl $200 at pH

4.5

(72).

Preparations

were

assessed

for

purity

and

characteristic antigenicity by immunoelectrophoresis and

SDS-polyacrylami’de gel electrophoresis. Purified proteins
were dialyzed against

PBS, pH 7.5, and passed through

0.45m

pore filters prior to being used in culture. LPS (Salmonella

typhimurium) was purchased from Calbiochem-Behring.
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Cell

isolation

and

Human monocytes were

culture.

isolated by counterflow centrifugation

(7). Briefly,

described

citrated

(CC) as previuosly

fresh human blood,

obtained by venipuncture, was separated by ficoll-Hypaque

density gradient centrifugation to yield a highly enriched
mononuclear

cell

fraction.

This

cell

platelet

subjected to CC during which

fraction

was

then

and lymphocyte elution

was monitored by electronic sizing of effluent cells from CC

(Coulter ZM-counter, Coulter Electronics, Hialeah, FL). Once
the

monocyte

fraction

had

been

centrifugation was terminated and

sufficiently

enriched,

monocytes quickly eluted

from the separating chamber. Monocytes were then pelleted in

Ca-Mg free PBS with I autologous

citrated

plasma

and

resuspended in appropriate medium for culture inoculation.
The cells were resuspended in a known volume of MCDB

!04 containing IZ FCS, 100 U/ml penicillin, and I00 mcg/ml
streptomycin, and monocyte recovery determined by electronic
counting.

The

cell suspension was then diluted to achieve a

concentration of 1.0-1.3 x
were placed in glass wells

106

cells/ml

ml aliquots

(18 mm diameter). For experiments

evaluating labelled AA metabolism,

monocyte suspension at 0.1

and I

Ci/ml

[3H]AA

was added to the

and cells inoculated at

the same density. All cultures were then incubated at
for 2 hr in a humidified atmosphere of
which

the

cultures

unincorporated label

were

washed

2

5 CO 2

times

37C

in air after

to eliminate

and/or nonadherent cells. Cultures

were

6O

(15 ug/ml) or LPS (10

then treated with media containing C3b

ug/ml) vs control medium.
At 2 8 16
was

and

24 hr, the cell-conditioned

replaced with identical fresh-medium

(CM)

medium

and

the

CM

centrifuged at 2500 x g for 5 mino Supernatants were then
stored frozen under N 2 in sealed glass tubes until analyzed

by RIA for PGE and TXB 2. In the case of labelled cultures,
medium was exchanged at identical time points and 100 ul of

supernatant counted to determine

[3HI

release. The remaining

supernatant was stored as described above until extraction
of labelled AA metabolites.

RIA for PGE and TXB 2. Immunoreactive PGE present in the
culture supernatants was determined by radioimmunoassay
using ammonium sulfate precipitation of monoclonal anti-PGE 2

PGE

antibody.

content

of

culture

supernatants

was

extrapolated from logit-log PGE 2 standard binding with each

assay (detection limit of 100 pg/ml). PGE 2 stock solution
was diluted in Tris buffer (10raM Tris, I0 mM NaC1. pH
with 2

mg/ml human gamma globulin) to give

7.6

dilutions of 100

to 50,000 pg/ml. Anti-PGE 2 stock solution was prepared by
diluting 20

l

monoclonal antibody stock in I ml of Tris-

gamma globulin buffer. PGE content was then determined by

[3H]PGE 2
ammonium

counts remaining in the assay supernatant after
sulfate

precipition.

All

determinations

carried out in duplicate and the average

pair used to calculate PGE content.

were

counts for each

Regression coefficients
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of logit-log standard curves were generally greater than

0.990.
by

Absorption

charcoal

activated

than

rather

immunoprecipitation was used to determine TXB 2 by RIA.
solutions were prepared in Tris buffer (SOmM Tris,

All

140mM

gelatin). Anti-TXB 2 stock solution
was prepared by diluting 1 vial of antibody (Seragen) in 20

NaC1, pH 7.4, with 0.

ml

Tris-gelatin buffer.

of

Generally,

10

l

of

culture

supernatant was assayed for TXB 2 content. TXB 2 content was
determined by supernatant

absorption

Norlt-A

of

[3H]TXB 2
unbound

commercially available kit
unknowns

and

curve

were

counts remaining after

TXB 2

according

to

a

(Seragen). The TXB 2 standard
calculaJted

by

logit-log

transformation and linear regression as with PGE RIA.

Labelled arachidonic acid metabolite extraction and
separation. AA metabolites were extracted by first adjusting
the pH of culture supernatants to 3.0 with formic acid

(70)

followed by two 3ml washes with ethyl acetate. The combined
organic extracts were evaporated under vacuum and stored at

-20C
AA

under

(5g),

sample

N2.

Prior to TLC separation of AA metabolites,

TXB 2

and

the

(5g),

and PGE 2

(5g)

silica gel

washes

added to each

contents dried under a stream of N 2.

Individual samples were dissolved in

vortexed,

were

I01

and spotted on LHP-K plates

of chloroform,

(precoated 200

m

G, Whatman). This was followed by 3 additional

with

5

i

of

chloroform,

spotting

each

wash

62
immediately below the previous application. Plates were then

developed in I dimension with chloroform:methanol:acetic

acid:H20

(90:8:1:0.8 v/v) (98). After drying, the plates

were sprayed with fluorescent indicator (I TNS in 50 mM

Tris, pH 7.4) and lipid spots visualized with UV light. AA
metabolites

were

standards

after

identified
which

by

comigration

spots wer.e

with

authentic

scraped and

counts

determined.

Phospholipid extraction and separation. Phospholipids
were

extracted

directly

from

glass

wells

using

a

modification of the method of Billah et al.

(8). Briefly,

wells

0.5

were

washed

4

with

times

ml

of

chloroform:methanol:HC1 (10:20:1 v/v) after which fewer than
100 cpm could be recovered from any well. The pooled organic

extracts from individual wells were then brought to 4 ml
with the same extraction solvent followed by the addition of

1.2 ml of 2 M KC1 and 1.2 ml of chloroform. The samples were
vortexed and centrifuged for 5 min at 1500 x g to facilitate

phase

separation.

The upper phase

was discarded and the

lower organic phase transferred to Reacti-vials and dried
under a

stream of N 2.

The extraction efficiency of this

method was found to be virtually identical to the neutral

pH-high salt extraction procedure of Garbus et al. (24).

Phospholipids

were

separated

by

1

dimensional

TLC

employing the following solvent system, chloroform:ethan-

ol:triethylamine:H20 (30:34:35:8 v/v) (95).

One dimensional

phospholipid separations were used as a preliminary means to

identify alterations in
this

3HIAA

lipids

separation,

content of phospholipids. For

Were

dissolved

in

chloroform, vortexed, and spotted on LHP-K plates (precoated
200

m

G, Whatman). The sample vial was then

silica gel

washed

times with

5

l

of chloroform,

spotting each wash

immediately below the previous application. The plates were
then

developed

above).

and

lipids

visualized

with

Z TNS (see

Individual lipids were identified by comigration

with authentic

standards and

counts determined by scraping

spots.
Results:
Release

of

prelabelled with

radiolabel

[3H]AA.

in

culture

medium

by HMP

Figure 1 shows the effect of C3b on

appearance, in medium equilibrated with HMP monolayers
attached to both glass and plastic culture wells

[3H]AA

diameter, Falcon). HMP were labelled with
and

washed free

(16 mm
for 2 hr

of any unincorporated label prior

to

stimulation. Plastic and glass cultureware were compared

because

investigations

previous

eicosanoid

release

dishes only

have

(72,80,73).

utilized

of

C3b

effects

on

HMP

cells attached to plastic

The use of glass wells facilitated

direct organic extraction of cellular phospholipids which

was not possible with plastic culture ware. As can be seen,
comparable

[3HI

release

was

adherent to glass and plastic.

observed

for

HMP

cultures

It should be emphasized that

Figure I. Comparison of time dependent

control

or

K3HI

release from

C3b treated HMP cells attached to glass or

plastic culture wells. Culture supernatants were obtained by

centrifuging HMP conditioned medium at 2500 x g for 5 rain.
Each

determination

represents

the

mean

+_ S.E.

for

trials. The release values are for plastic wells with either

control medium

()or

15 ug/ml C3b

(S)

()

and for glass

5 ug/ml C3b

wells

with

().

All subsequent experiments utilize HMP attached to

either

glass dishes only.

control

medium

or

700"
60C)"

50O

T

400300
20O
10(7

Hours

67
Figure

2.

C3b dose dependent

culture. Control
for

8 trials.

(E)

release

from

release represents the mean

For all other determinations,

concentrations

ere

g/ml,(U),

g/ml

1.5

3HI

as follows:

(

),

0.05

and 15

)g/ml

g/ml

(

HMP

+_

S.E.

n=.

(),
).

in

0.15

68

6O
50

40
30
20
10

.:::’.,

0-2

Hours
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doses of C3b also did not stimulate release of

K3HS

over

control cultures.
Effects of C3b on

[3H]-phospholipid content.

demonstrates the time dependent alterations in
within HMP

lipid classes with and without

Figure 3

[3H]AA

label

C3bstimulation.

As shown, C3b reduced the label within PI and PC without
affecting labelling of PEo C3b increased therate of

K3HS

label clearance from PC and PI for up to 8 hr of stimulation
afte which label clearance was reduced to that seen in
control

It

cultures.

migrating at the solvent front
lipids,

increased

[3HI

This

stimulation.

interesting

also

was

that

lipids

(Unk.), presumably neutral

content between 2 and 8 hr after C3b

increase

coincided

with

maximal

the

decrease in PI and PC labelling following C3b stimulation.
+/-n

these

dimensional TLC

experiments,

lipids

were

separated

by

I

(see methods) as a preliminary evaluation of

of alterations in label distribution. Definitive studies are
now in progress to confirm these results by 2 dimensional

TLC

and

to

extend

this

study

to

identify

phospholipid

turnover events in association with alterations in

[3H]

label distribution following C3b treatment.
The

data

in

Figure

3

also

demonstrate

the

time

dependent redistribution of label between lipid classes
within control or C3b stimulated HMP.

that 2 hr exposure to exogenous

These results indicate

[3H]AA

resulted in label

incorporation primarily into PI, PC, and presumably

neutral

7O
Figure 3. Effect of C3b on

K3HS

label content of selected

HMP lipids. Each point represents the mean
trials.

solvent

With

the

front

exception

(Unk.),

phosphatidylcholine

(PC),

of

lipids

+_

S.E. for 3

migrating

phosphatidylethanolamine
and phosphatidylinositol

at the

(PE),

(PI) were

identified by comigration with authentic standards. Data

points represent control medium

(@) and 5

g/ml

C3b ( I ).
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6OOO-

cm PE

cpm PC

0

106

cells

"’

cells4000.

’...

/

2

!8

8

24

Hours

2000

Clan,

cpm PI

Unk.

-’ cells-"

106 cells

I0

2O00-

40OO

2

16

8

Hours

24

2

8

16

Hours

24

liplds

to

Subsequent

absence of exogenous

this

3H]AA,

PI, PC, and neutral lipids
increasing

time

in

uptake,

initial

and

the

in

label was redistributed from

into PE and other lipids with

culture.

phenomenon

This

was

also

suggested by the label distribution observed in HMP lipids

following 2 or 26 hour exposure to identical amounts of

3HAA.

PI and PC demonstrated only modest increae

(approximately 25) in
exposure to
than

3H]AA

[3HI

content with an additional 2 hr

whereas PE and PS demonstrated greater

mfold increased labelling between 2 and 2/+ hr in

(data not shown).

culture

C3b and LPS stimulated release
determined

xg/mi)

-s

of

PGE and TX. 2

RIAo Figure % shows the effect of C3b (i.5

on TX 2 and PGE release from HMP cultures derived

from 2 donors. As with

[3H]

release from HMP cultures, the

release of AA metabolites was cumulative over the indicated
time

interval

The

time

course

of

TXB 2

release

was

considerably different from PGE release. When metabolite
release was expressed in ng/hr,

TXB 2 release demonstrated a

maximal rate during the 2-8 hr time interval whereas PGE

release was maximal after 16 hr of C3b stimulation.
Figure 5 demonstrates the effect of LPS and C3b on PGE

release from HMP cultures prepared from the same donor. The
release of PGE from HMP control cultures in this preparation
was

appreciable,

Figure 5.

in -contrast

to

the

Conversely, C3b-stimulated

control
release

release
of

PGE

in

was

Figure

.

following

course of TXB 2 and PGE release from HM

Time

stimulation

with

C3b

(15

#g/ml).

Each

value

()

and
represents the mean +_ S.E. for 6 trials for TXB 2
PGE
Values represent the average response for HMP

().

isolated from 2 donors.
did not exceed I

xceed 0.1

TXB 2 release from control cultures

ng/ml and PGE release

ng/ml.

from controls did not

-

IOO
8o

ng F__3

2

60
4O

"t
0-2

2-8

ng PGE
ml

8-16

Houm,

16-24

Figure 5. PGE release from HMP cultures stimulated with C3b
or LPS.

Each point represents

the

mean +

S.E. for 6

trials. HMP were isolated from the same donor. The release

values are for control medium

15

g/ml

C3b

().

(),

10

g/ml

LPS

(),

and

,l.

PGE
mi

0-2

2-8

8-1

Hours

16--24

comparable to that observed in Figure 4. A previous report
has also noted considerable variation in the stimulated and

control

levels

different

donors

rg/ml)demonstrate
time

interval,

PGE and TXB 2 released

of

cells

by

(72). Cultures stimulated

from

with LPS

(I0

maximal release of PGE during the 2-8 hr

considerably earlier than was observed with

C3b. However, C3b treated cultures appeared to achieve the
same rate of PGE release as the LPS-treated cultures by

2

hr. No TXB 2 RIA was carried out on these samples. Whether

C3b and LPS mediate different effects on HMP eicosanoid
production will be the subject of future studies.
Determination of labelled

AA, TXB2, and PGE 2 levels

in

HMP culture supernatamts. Figure 6 shows the time dependence
of labelled

AA ,TXB2,

and PGE 2 release from HMP cultures

following stimulation with C3b. As in previous experiments,
the metabolite release was cumulative only for the indicated

time interval. Stimulated release of

up to

8

hr

K3HSAA

was observed for

after C3b treatment followed by a return to

control release levels. In

contrast,

K3HSTXB 2

and

K3HPGE 2

release was not stimulated during the initial 2 hr interval
after C3b treatment but was maximally stimulated during the

2-8

hr

interval.

In addition,

continued

stimulation

of

labelled TXB 2 and PGE 2 release was observed for the 8-16 hr
interval.

Also

noteworthy

was

the

similar

pattern

of

labelled metabolite release between TXB 2 and PGE 2 whereas

TXB 2 and PGE release determined by RIA were found to be

78
Figure 6. Effect of C3b on

3H]

labelled AA, TXB 2, and PGE 2
release from HMP. Each value reprasents the mean + S.E. for

3 trials.

The values represent labelled metabolite

for control medium
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considerably different (see Figure

4). In addition, the

significant C3b effects on labelled metabolite release have
been corroborated by HPLC analysis of conditioned medium

extracts from parallel experiments. A complete report of the
HPLC results is in preparation.
LPS stimulation of

K3HSAA

labelled HMP in culture gave

a similar pattern of labelled metabolite release.
shows the time dependent release of labelled

Figure 7

AA, TXB2, and

PGE 2 from HMP cultures stimulated with LPS
used in this
Figure 5.

experiment were the

As shown,

labelled AA

same as those used in
release

was

stimulated

during the 0-2 hr interval of LPS stimulation but returned

to control values thereafter. Labelled TXB 2 and PGE 2 release
were not stimulated for up to 2 hr. Labelled TXB 2 release

was maximally stimulated during the 2-8 hr interval and

subsequently returned to control levels. In contrast to C3bstimulated

metabolite

release,

significant

release

labelled PGE 2 was not observed after stimulation with LPS.

of

Figure 7. Effect of LPS on

3H

labelled

AA, TXB 2,

and PGE 2

release from HMP. Each value represents the mean + S.E. for
trials.
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Discussion:
The time interval assessment of radioisotope release
from

K3HSAA

labelled HMP served to identify intervals of

varying metabolite release.
described in this

Although the time intervals

report were empirically developed from

experimental trials,

they were

previously reported differential
release

observed

from

C3b

to address the

intended

rates

of

stimulated

PGE and TXB 2

(80).

HMP

The

desirability of breaking the stimulation period into several
intervals relates to the nature of the metabolite release.

As has been observed in several reports,

cumulative

metabolite release from stimulated macrophages and

AA

monocytes

typically demonstrates a rapid initial release which tends

to plateau with increasing time of stimulation. Hoever,
calculation of the average rates of metabolite production

becomes less precise when approaching the plateau region of
cumulative metabolite release.

Yet,

this is the time period

where differential TXB 2 and PGE release has been observed
from

C3b-stimulated HMP

discrete

intervals,

it

(80).
was

By

exchanging

medium

to

a

possible

obtain

at

more

sensitive measure of average rates of metabolite release

during the attenuated response period. This approach assumes
that metabolite production during the early time periods
does not alter subsequent metabolic events. However, as will
be

shown,

comparison of our results

demonstrates

that

our

with previous

experimental

design

findings
does

not

discernably

the

affect

biological

response

previously

characterized for HMP.
According

to this construct,

it

was possible to

identify four intervals demonstrating different average

rates of radioisotope release following C3b stimulation of

HMP. These intervals were as follows: 0-2 hr interval of
increasing label release,

2-8 hr interval of maximal label

release, and 8-6 and $6-2 hr intervals of decreasing label
release.

With

intervals

some

experiments,

demonstrated

responses,

when

stimulation of

approximately

expressed

K3HSAA

the

as

cpm

0-2
the

hr

and

same

2-8

hr

average

released/hr.

LPS

labelled HMP produced a very simi:ar

pattern of radioisotope release to that observed in C3 b
stimulated HMP.
in this same

However, C3b did not stimulate

[3HI

release

HMP cell preparation. Previously, it was shown

that HMP prepared from fresh blood

demonstrate a time-

dependent loss of C3b-stimulated PGE-and TXB 2 release that
was not correlated with a decrease
cell numbers

(79). The loss

with aged buffy coat HMP

in C3b receptor-bearing

of C3b responsiveness observed

may represent the same process

since these cells were obtained approximately

24 hr prior to

HMP separation and culture. Future studies will address this
question.

[3H]AA

incorporation into HMP phospholipids

was

comparable to that observed previously in rodent macrophages

(83,64). [3H]-AA

was incorporated primarily into PC after 2

hr exposure whereas exposure to

K3HSAA

for 26 hr resulted in

much greater percentage of label incorporated into PE

(data

not shown). The tlme-dependent redistribution of label in

HMP observed as a net loss of label from PC and PI and a net
increase of label in PE, has also been observed in mouse

macrophages (83).

C3b-stimulated

K3HS

label release from PC

and PI without affecting PE label content is

in_general

agreement with previous reports demonstrating zymosan and fmet-leu-phe stimulated label release from PI and PC in
rodent macrophages prelabelled with

K3HAA

(I06,6). Also

noteworthy is the recent report demonstrating decreased PI
sphingomyelin levels in HMP treated

and increasing LPC and
with

C3b (42). Taken together with the present findings,

appears

that

decreased

3HS

label

it

PI may reflect

in

increased breakdown of PI whereas decreased label in PC may

reflect increased turnover of PC without a net breakdown of
this

phospholipid.

Experiments

evaluate these possibilities.

are

now

in

progress

to

The observed transfer of

label into lipids migrating at the solvent front suggests
that

neutral

accumulate

lipids

label

following

C3b

stimulation of HMP. This is consistenlt with the report of

Bonney et al. (64),

where a net transfer of

triglycerides was

observed

[3HI AA-labelled

mouse

with

macrophages.

[3HI

label into

zymosan stimulation of
These

results

therefore

indicate that medium exchanges at the described intervals
do not adversely affect

[3HI

label release from HMP lipid

pools. C3b-stimulated release of PGE and TXB 2 from HMP in
this study is in general agreement with previous reports.

Rutherford

and

Schenkeln
stimulation

of PGE release

demonstrated

maximal

that

20-24 hr after C3b

occured

treatment of HMP with little or no release during the first

4 hr of stimulation (80). In contrast, TXB 2 release was
stimulated by I hr and appeared to be approximately linear
24 hr exposure to C3b (80). These results were

over the

established for HMP treated with C3b at the time of culture
inoculation and for culture medium containing 1 FCS. In

agreement with the results of Schenkein et al. (72,80), we

6.-24

observed maximal PGE release during the

hr interval

after C3b stimulation. Our results differ only in that ,e

observed
release

a

time

hich

dependent

was

increase

detectable

in

during

rate

the

the

PGE

of

initial

2

hr

exposure to C3b.
The apparent differences in the time course of TXB 2 and

PGE release from stimulated HMP suggest either
regulation of eicosanoid metabolism

PGE is predominantly PGE 1.

The

selective

or that immunoreactive

latter possibility is

unlikely since the fatty acid composition of human monocytes
has been shown to include 20Z arachidonic acid

significant levels of linolenic acid

(87,64),

(87)

the precursor

fatty acid for dihomo-g-linolenic acid (DHL).
converted

to PGE I

by

way of

with no

cyclo-oxygenaseo

DHL is
Mouse

peritoneal macrophages have been shown to synthesize PGE 1

when prelabelled for

and

stimulated

4 hr

with

[3HSAA

acid

(DHL)

(11). However, parallel

zymosan

with

experiments using

3HSeicosatrienoic

as label demonstrated PGE 2 as the

predominant PGE metabolite released from zymosan treated

mouse MP (29). In our experiments, the possibility exists
that

fetal

calf

linolenic acid
stimulated

serum

and/or DHL

HMP.

amounts

of

which was converted to PGE I

by

provided

Deletion

of

significant

fetal

calf

serum

HMP

from

culture medium would therefore be expected to reduce PGE
release

without

affecting

TXB 2.

However,

PGE

and

TXB 2

release from C3b stimulated HMP were equally diminished

(approximately .$0%) with the removal of fetal calf serum
from

culture

medium

selectively and

conditions,

(80).

Because PGE release

was

not

substantially diminished under these

these results suggest that fetal calf serum

is

not promoting PGE I production in stimulated HMP.
The time course of immunoprecipitable TXB 2 and PGE
release from C3b-stimulated HMP suggests regulation of AA
metabolism so that TXB 2 is produced earlier than PGE. This
could

result

enzyme regulation which

from

preferentially

catalyzes AA conversion to TXB 2 during early time periods

followed by a subsequent increase in the conversion of AA to
PGE 2. This possibility was examined by measuring the time
course of radiolabelled AA conversion to TXB 2 and PGE in
2

C3b

stimulated

HMP.

immunoprecipitable

It

was

found

that

labelled

and

TXB 2 release were very similar whereas

88
the release of labelled PGE did not parallel the release of

immunoprecipitable PGE. Assuming that +/-mmunopreclpitable PGE
represents primarily

.

specific activity of
and

6),

PGE2,
PGE2,

these results indicate that the
expressed in

cpm/ng (see Figures

declined over the 2/. hour stimulation period while

the specific activity of TXB remained
2

Becaus.e .cyclo-oxygenase

conversion

virtually unchanged.

of AA to

PGG 2 serves as

the single common pathway for the production of TXB and
2

PGE2,

these

results are inconsistent with a time dependent

shift in enzymatic production from TXB initially to PGE
2
2

subsequently. Instead, these results suggest that C3b and
LPS stimulated HMP synthesize TXB and PGE from independent
2
2
cell sources of AA. The LPS effects were included in this
manuscript because they demonstrated the same basic patt6rn
of labelled and immunoprecipitable metabolite release as was

demonstrated by C3b.

That independent metabolism of AA can

occur in C3b- and LPS-stimulated HMP is also suggested by
the early release of labelled AA into

culture supernatants

without the appearance of labelled metabolites. In addition,
the time course of label disappearance from phospholipids of

C3b-treated HMP correlated only with the appearance of
labelled TXB 2. A similar increase in label release was not

observed during the period of maximal PGE release from C3bstimulated HMP. It is possible that longer labelling periods
with
in

K3HSAA

HMP

to

are required to label the requisite lipid pools

observe

parallel

release

of

labelled and

89
immunopreclpitable PGE 2.
The possibility of independent AA metabolite production

has been suggested in other reports.
resident

Using elicited and

mouse peritoneal macrophages,

Scott et al. (82)

demonstrated that AA incorporation into lipid pools can be

independent of synthesis of AA metabolites.

Stobo

extended

exogenous

this

K I4CSAA

observation

by

Goldyne and

demonstrating

that

previously released by T cells could be

converted to TXB 2 in human macrophages

(28). However, no

labelled PGE 2 was detected in the same culture medium even
in the presence of elevated immunoprecipitable PGE release.

Because PGE levels were 15-20 of TXB 2 levels by RIA, itwas
suspected that [’i/,C]PGE 2 counts would be indistinguishable
from background counts in the chromatographic separation.

Our studies suggest that Goldyne and Stobo did not observe
labelled PGE 2 release because
into the requisite

metabolic

SCSAA

had not equilibrated

compartment for conversion to

PGE 2. Studies are now in progress to examine the AA lipid
pools in HMP which give rise to PGE 2 and TXB 2.

Thesis Discussion:

The previously described studies compare arachidonic
acid

in two different

(AA) metabolism

cell types following

treatment with respective soluble agents known to elicit
biological responses.

7/2"8,

demonstrate

The osteoblast-like clonal cells,
little

phospholipid-AA metabolism

Conversely,

ROS

any capacity to alter

if
when

stimulated

human mononuclear phagocytes

with

(HMP)

exhibit pronounced alterations in phospholipid

_n

PTH.

xi__tro_

AA metabolism

when stimulated with C3b. The variability in responsiveness

demonstrated in the present study is not inconsistent with

responses noted in other cells.

Some hormones have been

shown to be without effect on phospholipid or AA metabolism
in

their

respective

Conversely,

target tissues,

i.e.,

glucagon.

very pronounced alterations in phospholipid

metabolism and increased AA release have been observed in

hormonally or chemically stimulated cells, particularly
The variation in cell responses observed

white blood cells.

in the present study were therefore not entirely unexpected.

The lack of PTH effects on ROS cell phospholipid-AA
metabolism was in

and

inhibition

contrast to PTH stimulation of cAMP levels

of

alkaline

phosphatase

activity.

These

findings indicate that ROS cells express osteoblast-like
responsiveness to PTH when grown in microcarrier culture.
The lack of PTH effects on phospholipid-AA metabolism in ROS

cells grown in microcarrier culture contrasted with the

9O

91
previously
metabolism

effects

reported
in

P04

release from bone,

regulate Ca reabsorptlon and

thus,

phospholipid

on

(5). In addition to physiological

kidney

regulation of Ca and

PTH

of

P0

PTH acts to

clearance from kidney;

kidney is another important target tissue for PTH

action. Stimulation of dog kidney with PTH has been shown to

decrease PI levels, increase labelled

P04

uptake into PI and

PA, and to increase prostaglandin synthesis (5). Although

ROS

cells

and

responsiveness

with

two

demonstrate

kidney

extremes

of

PTH

respect to phospholipid-AA metabolism,

variation in tissue responsiveness of this magn_tude has

been observed with other chemical agents. For

example,-

adrenergic stimulation of cerebral cortex is without effect
on

phospholipid

tissues,

metabolism

whereas

including vas differens,

treatment

of

with 2-adrenergic

other

agents

can produce significant alterations in phospholipid turnover

(60)o

The

effects

of

PTH on R0S

cells

observed

in

the

present study are therefore not unique.
The ability of ROS

17/2"8 cells to produce PGE 2 in

culture is a perplexing issue. Particularly noteworthy is
the capacity of PGE 2 to stimulate osteoclastic-mediated bone
resorption

n_

_vi__tr__o and in _vi_v (,78).

However, PTH-

stimulated osteoclastic resorp.tion in organ culture has been
shown to be independent of prostaglandin release (51,66).
The observed release of PGE 2 from R0S

17/2"8 cells indicates

the presence of cyclo-oxygenase enzyme activity.

However,

it

92
does not explain the source of AA for conversion to PGE 2.
is possible that

substrate

for

It

AA present in the culture medium served as

the

production

of

PGE 2.

This

possibility

appears likely since labelled PGE 2 release from ROS 1’//2"8
cells was

greatest during the initial 2 hour period of

exposure to

KI4CSAA

(7).

Presumably,

the rate

of PGE 2

release diminished due to the uptake of exogenous AA into

ROS lipids thereby reducing labelled AA availability to

cyclo-oxygenase enzyme systems. It is also possible that

KI%HSAA

may transiently label a lipid/phospholipid in ROS

cells which turns over rapidly and provides free AA for
conversion

to

PGE 2.

However,

AA

labeling

of

OS

phospholip.ids has not confirmed the presence of transient
phospholipid labeling.

In summary,

it is uncertain how ROS

cells regulate AA metabolism such that basal production of

PGE 2 occurs at a significant rate.
The microcarrier culture system used in the present
studies was unique in that cells were grown in monolayer

culture attached to very small dextran beads
suspension

through gentle stirring.

maintained

in

ROS cells demonstrated

comparable PTH responsivenness in microcarrier culture as

was previously observed for cells grown on conventional
plasticware. PTH responses assayed were stimulation of cAMP
and

inhibition

of alkaline phosphatase.

However,

there are

mechanical agitation properties associated with microcarrier

culture which might affect PGE 2 release. ROS cells have been

shown to increase PGE 2 release when subjected to mechanical

(107), as

stretching

has been observed in many other cell

types including flbroblasts
microcarrier

culture

The

possibility that

alterations

induced

[3H]

was examined by comparing

(62).

AA metabolism

in

[3H]AA

release .from

labelled

R0S cells maintained in microcarrier and stationary culture.

It was found that label release was identical for both
transfer of cell samples from

culture systems. In addition,
microcarrier

associated

culture

with

phospholipid
microcarrier

to

stationary

[3H]AA

any redistribution of

classes.
culture

These

does

not

was

culture

ithin

suggest

results

significantly

not

that

affect

endogenous AA metabolism in R0S $7/2"8 cells.
The Ca ++ ionophore,

A-23187, was the only agent in or

study which st..mulated labelled AA release from R0S cells.

A-2387 facilitates Ca ++ influx into cells which stimulates
phospholipase A 2 activity and AA release from phospholipids.

A 231 87 has been shown to be ineffective in other cell
systems in the absence of extracellular Ca ++ (55). In
addition,

the

Ca ++ binding protein,

calmodulin,

is

implicated in A-23187 activation of phospholipase A 2,
the

calmodulin inhibitor,

block A-23187 effects

on

(TFP),

trifluoroperozine
phospholipase

(104). PTH was expected to produce

A2

in

also
since

will

platelets

a response similar to A-

23187 since PTH has been shown to stimulate

45Ca

uptake into

osteoblast enriched populations of freshly isolated bone

cells

(18,19).

Enhanced uptake of

45Ca

uptake is generally

accepted as a measure of increased uptake of Ca ++ by cells.
Since R0S

7/2"8 cells demonstrate comparable PTH responses

to osteoblast-enriched populations of bone cells, it was
anticipated that the R0S cell line would serve as a good
model to test this hypothesis. Because a significant dose of

PTH had.avirtually insignificant effect on AA release from
EOS cells relative to A-23187, it appears that PTH does not
elicit effects on R0S cells through a

mechanism

comparable

to A-231 87.
The

inability

metabolism in R0S

of PTH

to stimulate endogenous AA

17/2"8 cells does not necessarily

that hormonally stimulated osteoblasts

_n

indicate

_vi_v_o_ or in primary

culture respond in a similar manner. Recent evidence has

shown

PTH stimulation of PGE production in osteoblast-

(53). In addition,

enriched cells

equally possible

it is

that bone cells other than osteoblasts respond to PTH with

an

in

increase

AA

endogenous

established which cell types

metabolism.

It

not

is

are responding under these

experimental conditions and the mechanisms regulating AA

However,

metabolism.

the

inability

populations of individual bone

makes
in

to

area

populations

conveniently

will
of

be

limited

individual

isolated.

pure

cell types from intact bone

these findings difficult to resolve.

this

isolate

un.til

bone

Future research

relatively

cell

types

pure

can

be

The characterization of AA metabolism in HMP was an
extension

of previous

Together

with

work by Rutherford and Schenkeln.

other

workers,

investigators

these

demonstrated enhanced 2 hour release of PGE and TXB 2 from

C3b treated HMP. C3b treatment was also shown to decrease

HMP

PI

levels

and

increase

lysophosphatidylcholine levels

sphingomyelin

over

the

same

and

treatment

period. This preliminary work suggested that phospholipid-AA
metabolism might be important in regulating PGE and TXB 2

release from HMP. The present study therefore examined this

relationship by comparing the time course of

3HSAA

release

from HMP phospholipids with the appearance of labelled PGE 2

and TXB 2

In our view, the most exciting aspect of the monocyte
studies

was

th. differeutial pattern of eicosanoid release

following stimulation with C3b or LPS.
occured

Labelled AA release

within 2 hours of C3b or LPS stimulation without

significant

conversion to labelled metabolites.

Conversely,

the delay in labelled TXB 2 and PGE 2 release following C3b

treatment was not associated with increased AA release
during

later

immunoreactive

time

intervals.

Lastly,

the

release

of

and labelled TXB 2 were very similar in C3b

treated cells whereas the time course of immunoreactive

and

labelled PGE release were considerably different for the
same cell samples. These results suggest a more complicated
metabolic

relationship

between

AA

availability

and

96
prostanoid

than

production

can

be

explained

enzyme

by

regulation alone.
The delay in TXB 2 and PGE 2 release from stimulated HMP

appears to be unrelated to feedback regulation of AA
release.

metabolite

Although

metabolite

release

determined in HMP-conditioned medium exchanged at

was

specific

time points, this method of sequential medium harvesting did

not appear to significantly alter the cumulative release of

TXB 2 or PGE.

immunoreactive

laboratory has
production

shon

at intervals

metabolite release over

mstabolite

that

2

is
hr.

Subsequent work in our

assessment

of

metabolite

comparable to cumulative
The sequential pattern

o AA

release from HMP is very interesting because it

may represent an additional aspect to monocyte regulation of
inflammation and tissue injury not addressed previously.

These results could have considerable importance to clinical
conditions which involve the release of prostanoids from

monocytes.
The sequential pattern of metabolite release is also

interesting with respect to mechanisms of C3b and LPS action
on HMP.

Human monocytes have been shown to possess cell

membrane receptors for the complement cleavage products, C3b
and iC3b. Without rendering a detailed explanation of the

complement

system

reviews), C3b

(for which there are

many

excellent

is a product of C3 convertase cleavage of C3

which can be activated by either the classical or alternate

complement pathways. The iC3b fragment is the product of C3b
cleavage

by

proteolytic

C3b

inactivator

activity.

Monocytes

result

also

may

but

have

been

from

shown

to

synthesize most complement proteins, including C3 as well as

C3b inactivator (98). The mechanism by -hich LPS stimulates

HMP eicosanoid production is unknown but could involve
cleavage on HMP membranes since LPS is a potent stimulator
of

the

alternate

complement

pathway.

LPS

generated

C3

fragments could then act through cell membrane receptors in
stimulating eicosanoid release. The essential point to be
made is that C3b or LPS stimulate very similar patterns of

AA metabolits release from HMP.

In addition,

the increased

metabolite release occurs after a delay of at least 2 hours
after factor treatment. The release of labelled AA during

the initial 2 hour treatment period probably represents

plasma

membrane phospholipid alterations

more

directly

associated with C3b or LPS membrane receptor interaction or

LPS treatment. On the other hand,

the delay in peak release

of TXB 2 and PGE after C3b or LPS

treatment suggests that

perhaps protein synthesis and/or RNA synthesis must take
place for stimulation of metabolite production.

Because the

time between factor treatment and metabolite release is

considerable

and unusual,

this

cell

system may provide

insight into additional cellular mechanisms regulating

AA

metabolism.

As described in Chapter II,

the

differentiation of

98
from

immunoreactive

independent

metabolism

of

PGE

this

suggests

release

eicosanold from TXB 2.

it will be necessary to establish different

Ultimately,

[3HSAA

labelled

labelling conditions which demonstrate labelled PGE 2

release

in

It is

parallel with immunoprecipitable PGE.

presumed that these conditions will be different from those
already established for parallel i.mmunoprecipitable and
labelled TXB 2 release. The first approach to this question
.’i.ll be to use longer labelling periods

with

[3H]AA

prior

to stimulating with LPS or C3b. Longer labelling periods
should incorporate more

3HSAA

into cellular lipid pools as

ll as allow for greater redistribution of AA into more
slowly

equilibrating lipid pools.

The

previous

results

suggest that most PGE can only be derived fom a lipid pool
which labels very slowly in the presence of exogenous

K3HIAA

but which contains or is provided ith significant amounts
of unlabelled AA under stimulated conditions. By exposing

cells to

K3HSAA

for longer periods, it should be possible

incorporate sufficient label into these sequestered lipid

pools

to

measure

K3HSPGE 2

release

which

parallels

immunoprecipitable PGE release.
Another approach to this problem is to determine the
time course of AA Ibss from

lipid classes in HMP follozing

stimulation with C3b or LPS. This approach is less sensitive

than the previously described labeling studies because of
the

complex

lipid

manipulations

and

because

of

the

relatively low

levels

AA held within certain lipid

of

classes in HMP. Hewever, this approach should alse provide
insight

into

the

lipids

hich

are

contributing

to PGE

release as well as TXB 2 and AA release.
The preliminary determinations of C3b-stimulated

3HAA

release frem HMP phospholipids indicate that AA is released
principally from PI and PC.

Further

examination

of C3b

effects on HMP phospholipid labeling has been delayed so
that a more extensive characterization of HMP phospholipids

can

be

carried out.

Recent data have demonstrated that

rabbit and guinea pig macrophages possess significant levels

of alkenyl-acyl and alkyl-acyl

(CPG) and

choline

phosphoglyceride

ethanolamine phosphatidylglyceride

(EPG) (89,90).

Alkenyl-acyl and alkyl-acyl phospholipids are distinguished
from diacyl lipids in that the chemical moiety linked to the
position of glycerol forms an ether or an alkyl bond. Also

noteworthy is that alkenyl and alkyl phospholipids of rabbit
and guinea pig macrophages contain significant levels of AA

(90) and that alkyl-acyl CPG may serve as

a

precursor

molecule in the synthesis of platelet activating factor

(PAF). PAF has been shown to

stimulate PGE and TXB 2 release

from peritoneal macrophages.

Alkyl-acyl

and

ether-acyl

phos.pholipids

cannot

be

discriminated from diacyl phospholipids by conventional
and

2

dimensional

thin

layer

chromatography.

However,

methods are now available to conveniently characterize all

100
three

c!as ses

of

these

phospholipids

(94).

Because

release from PC is stimulated by C3b treatment of

HMP,

AA

it is

important to determine whether this release is selective for
a particular class of choline phosphoglyceride.

Experiments

are therefore planned to first determine whether HMP contain

significant

levels

of

alkenyl-acyl

or

ether-acyl

phospholipids and subsequently examine whether C3b or LPS
can stimulate AA release.
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